期刊
WORLD ALLERGY ORGANIZATION JOURNAL
卷 2, 期 -, 页码 115-118出版社
BIOMED CENTRAL LTD
DOI: 10.1097/WOX.0b013e3181ac91ae
关键词
vasomotor rhinitis; epidemiology; nonallergic rhinopathy; nonallergic rhinitis
资金
- GlaxoSmithKline (GSK)
- Sanofi-Aventis Pharmaceuticals
- Meda Pharmaceuticals
- Alcon Laboratories
- TREAT Foundation (Washington, DC)
Vasomotor rhinitis is the most common form of nonallergic rhinitis, comprising approximately 71% of all nonallergic rhinitis conditions. Although the epidemiology of this subtype of nonallergic rhinitis has not been definitively studied, it is estimated that 14 million Americans suffer from vasomotor rhinitis, with a worldwide prevalence approaching 320 million.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据